Buy Biogen as stock looks ‘too good to ignore,’ Wells Fargo says Latest News By On Apr 18, 2022 0 14 Share Investors are underestimating Biogen’s Alzheimer’s drug and some of its other key businesses, according to Wells Fargo. 0 14 Share FacebookTwitterGoogle+ReddItWhatsAppPinterestEmail